Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Lipedematous scalp: Case report with radiologic, histopathologic, and management insights.
Journal: JAAD case reports
Published: September 05, 2026
Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study.
Journal: Journal of the American Academy of Dermatology
Published: September 15, 2022
Topical ophthalmic beta-blockers are associated with ocular pseudopemphigoid: A pharmacovigilance study of antiglaucoma medications utilising the FDA adverse event reporting system.
Journal: The Australasian journal of dermatology
Published: December 16, 2021
Case/noncase analysis of the FDA Adverse Events Reporting System suggests higher reporting odds of photosensitivity and esophageal symptoms for sarecycline than of those for other tetracyclines.
Journal: Journal of the American Academy of Dermatology
Published: November 30, 2021
Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schönlein purpura: A case report and review.
Journal: The Journal of dermatology
Published: September 05, 2021
DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020.
Journal: American journal of clinical dermatology
Published: June 28, 2021
Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine.
Journal: Dermatology online journal
Published: February 03, 2021
Polydactylous Squamous Cell Carcinoma of the Nail Unit: A Structured Review of the Literature.
Journal: Journal of cutaneous medicine and surgery
Published: December 01, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026